Duncan F. Muir

Duncan F. Muir

Auto-generated profile, based on publicly available information

Duncan F. Muir

Graduate Program in Biophysics, University of California, San Francisco, San Francisco, CA, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2025 in Science
Verified
Journal Article
Closed access
DMDuncan F. Muir
Duncan F. Muir
GAGarrison P. R. Asper
Garrison P. R. Asper
PNPascal Notin
Pascal Notin
JPJacob A. Posner
Jacob A. Posner
DMDebora S. Marks
Debora S. Marks
MPMargaux M. Pinney
Margaux M. Pinney
Quantitatively mapping enzyme sequence-catalysis landscapes remains a critical challenge in understanding enzyme function, evolution, and design. In this study, we leveraged emerging microfluidic technology to measure catalytic constants— k cat and K M —for hundreds of diverse orthologs and mutants of adenylate kinase (ADK). We dissected this sequence-catalysis landscape’s topology, navigability, and mechanistic underpinnings, revealing catalytically heterogeneous neighborhoods organized by domain architecture. These results challenge long-standing hypotheses in enzyme adaptation, demonstrating that thermophilic enzymes are not universally slower than their mesophilic counterparts. Semisupervised models that combine our data with the rich sequence representations from large protein language models predict orthologous ADK-sequence catalytic parameters better than existing approaches. Our work demonstrates a promising strategy for dissecting sequence-catalysis landscapes across enzymatic evolution, opening previously unexplored avenues for enzyme engineering and functional prediction.

19 November 2020 in Journal of General Physiology
Verified
Journal Article
Open access
PDF file
HLHannah A. Ledford
Hannah A. Ledford
SPSeojin Park
Seojin Park
DMDuncan Muir
Duncan Muir
RWRyan L. Woltz
Ryan L. Woltz
LRLU Ren
LU Ren
NCNipavan Chiamvimonvat
Nipavan Chiamvimonvat
Calmodulin (CaM) plays a critical role in intracellular signaling and regulation of Ca2+-dependent proteins and ion channels. Mutations in CaM cause life-threatening cardiac arrhythmias. Among the known CaM targets, small-conductance Ca2+-activated K+ (SK) channels are unique, since they are gated solely by beat-to-beat changes in intracellular Ca2+. However, the molecular mechanisms of how CaM mutations may affect the function of SK channels remain incompletely understood. To address the structural and functional effects of these mutations, we introduced prototypical human CaM mutations in human induced pluripotent stem cell–derived cardiomyocyte-like cells (hiPSC-CMs). Using structural modeling and molecular dynamics simulation, we demonstrate that human calmodulinopathy-associated CaM mutations disrupt cardiac SK channel function via distinct mechanisms. CaMD96V and CaMD130G mutants reduce SK currents through a dominant-negative fashion. By contrast, specific mutations replacing phenylalanine with leucine result in conformational changes that affect helix packing in the C-lobe, which disengage the interactions between apo-CaM and the CaM-binding domain of SK channels. Distinct mutant CaMs may result in a significant reduction in the activation of the SK channels, leading to a decrease in the key Ca2+-dependent repolarization currents these channels mediate. The findings in this study may be generalizable to other interactions of mutant CaMs with Ca2+-dependent proteins within cardiac myocytes.

25 October 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
DMDuncan F. Muir
Duncan F. Muir
GAGarrison P. R. Asper
Garrison P. R. Asper
PNPascal Notin
Pascal Notin
JPJacob A. Posner
Jacob A. Posner
DMDebora S. Marks
Debora S. Marks
MPMargaux M. Pinney
Margaux M. Pinney
Quantitatively mapping enzyme sequence-catalysis landscapes remains a critical challenge in understanding enzyme function, evolution, and design. Here, we expand an emerging microfluidic platform to measure catalytic constants— k cat and K M —for hundreds of diverse naturally occurring sequences and mutants of the model enzyme Adenylate Kinase (ADK). This enables us to dissect the sequence-catalysis landscape’s topology, navigability, and mechanistic underpinnings, revealing distinct catalytic peaks organized by structural motifs. These results challenge long-standing hypotheses in enzyme adaptation, demonstrating that thermophilic enzymes are not slower than their mesophilic counterparts. Combining the rich representations of protein sequences provided by deep-learning models with our custom high-throughput kinetic data yields semi-supervised models that significantly outperform existing models at predicting catalytic parameters of naturally occurring ADK sequences. Our work demonstrates a promising strategy for dissecting sequence-catalysis landscapes across enzymatic evolution and building family-specific models capable of accurately predicting catalytic constants, opening new avenues for enzyme engineering and functional prediction.

9 December 2024 in ChemRxiv
Verified
Preprint
Open access
PDF file
LSLaura Shub
Laura Shub
MKMagdalena Korczynska
Magdalena Korczynska
DMDuncan F. Muir
Duncan F. Muir
FLFang-Yu Lin
Fang-Yu Lin
AMAlan M. Mathiowetz
Alan M. Mathiowetz
MKMichael J. Keiser
Michael J. Keiser
Human inspection of potential drug compounds is crucial in the virtual drug screening pipeline. However, there is a pressing need to accelerate this process, as the number of molecules humans can realistically examine is extremely limited relative to the scale of virtual screens. Furthermore, computational medicinal chemists can evaluate different poses inconsistently, and there is no standard way of recording annotations. We propose Autoparty, a containerized tool to address these challenges. Autoparty leverages on-premises active learning for drug discovery to facilitate human-in-the-loop training of models that extrapolate human intuition. We leverage multiple uncertainty quantification metrics to query the user with informative examples for model training, limiting the number of human expert training labels. The collected annotations populate a persistent and exportable local database for broad downstream uses. Incorporating Autoparty doubled the hit rate among 193 experimentally tested compounds in a real-world case study.

22 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
NFNicholas J. Freitas
Nicholas J. Freitas
JZJonathan S. Zhang
Jonathan S. Zhang
DMDuncan F. Muir
Duncan F. Muir
HSHayden S. Saunders
Hayden S. Saunders
DADylan Aidlen
Dylan Aidlen
MPMargaux M. Pinney
Margaux M. Pinney
High-throughput enzymology enables quantitative characterization of enzyme function across hundreds to thousands of sequence variants and experimental conditions. Nevertheless, the scale and complexity of these datasets create substantial challenges for analysis and quality control. High-Throughput Microfluidic Enzyme Kinetics (HT-MEK), for example, generates large microscopy datasets that must pass through multiple analytical stages, including image processing, initial-rate fitting, and kinetic modeling. Choices or errors made at any stage can propagate into the final kinetic parameters without being evident from fit statistics alone. Here, we provide a broadly applicable guide for analyzing high-throughput enzymology data from the HT-MEK platform, using Michaelis-Menten kinetics as a representative example. We first outline the conceptual workflow from raw fluorescence measurements to estimates of k cat , K M , and k cat / K M . We then discuss common experimental and analytical failure modes and present a framework for deciding when data should be refitted, filtered, qualified, or repeated. Finally, we provide a step-by-step workflow using Mercury , an open-source Python framework that integrates scalable HT-MEK data processing with traceable quality control and diagnostic visualization. This workflow preserves the connection between reported parameters and their underlying measurements and can be adapted to other kinetic models and biochemical assays.